Sign up for our Oncology Central weekly news round-up

IKEMA study: improving outcomes for multiple myeloma patients

Clinical trials Hematologic Quality of life and outcomes

In this video María-Victoria Mateos, Consultant Physician in Hematology from the University of Salamanca (Spain) discusses recent multiple myeloma data, including the IKEMA trial subgroup analysis, which was presented at the 64th ASH Annual Meeting and Exposition (10−13 December 2022, AK, USA).

 

 

This video has been kindly supported by Sanofi through Oncology Central, which is editorially independent.